No abstract available
Publication types
-
Comment
-
Comparative Study
-
Editorial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Angiogenesis Inhibitors / administration & dosage*
-
Antibodies, Monoclonal / administration & dosage
-
Antibodies, Monoclonal, Humanized
-
Bevacizumab
-
Choroidal Neovascularization / drug therapy*
-
Choroidal Neovascularization / etiology
-
Choroidal Neovascularization / physiopathology
-
Humans
-
Injections
-
Macular Degeneration / complications
-
Macular Degeneration / drug therapy*
-
Macular Degeneration / physiopathology
-
Ranibizumab
-
Retreatment
-
Tomography, Optical Coherence
-
Vascular Endothelial Growth Factor A / antagonists & inhibitors
-
Visual Acuity / physiology
-
Vitreous Body
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Vascular Endothelial Growth Factor A
-
Bevacizumab
-
Ranibizumab